264 related articles for article (PubMed ID: 22356350)
21. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
22. Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.
Watts AM; West NP; Smith PK; Zhang P; Cripps AW; Cox AJ
Immun Inflamm Dis; 2022 Mar; 10(3):e571. PubMed ID: 34813682
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
[TBL] [Abstract][Full Text] [Related]
24. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
25. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays.
Baumann D; Bachert C; Högger P
Eur J Pharm Biopharm; 2012 Jan; 80(1):156-63. PubMed ID: 21945271
[TBL] [Abstract][Full Text] [Related]
27. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
28. Azelastine and fluticasone nasal spray: any advantage?
Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
[TBL] [Abstract][Full Text] [Related]
29. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
30. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
[TBL] [Abstract][Full Text] [Related]
31. MP29-02: a breakthrough for the treatment of allergic rhinitis.
Bernstein JA
Expert Opin Pharmacother; 2013 Oct; 14(15):2101-13. PubMed ID: 23977840
[TBL] [Abstract][Full Text] [Related]
32. A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.
Du D; Targett D; Stolberg E; Canali A
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):69-75. PubMed ID: 23681835
[TBL] [Abstract][Full Text] [Related]
33. Azelastine/fluticasone propionate(Dymista) for seasonal allergic rhinitis.
Med Lett Drugs Ther; 2012 Oct; 54(1402):85-7. PubMed ID: 23114738
[No Abstract] [Full Text] [Related]
34. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
[TBL] [Abstract][Full Text] [Related]
35. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
Kaulsay R; Nguyen DT; Kuhl HC
Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
[TBL] [Abstract][Full Text] [Related]
36. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
Kubavat AH; Pawar P; Mittal R; Sinha V; Shah UB; Ojha T; Khippal N; Patel T
J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
[TBL] [Abstract][Full Text] [Related]
37. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
[TBL] [Abstract][Full Text] [Related]
38. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers.
Qi W; Liu Y; Xue W; Li K; Gorski JC; Liu M; Yan T; Nguyen DT; Ramalingam RK
J Asthma Allergy; 2023; 16():667-677. PubMed ID: 37409000
[TBL] [Abstract][Full Text] [Related]
39. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects.
Howland WC; Hampel FC; Martin BG; Ratner PH; van Bavel JH; Field EA
Clin Ther; 1996; 18(6):1106-17. PubMed ID: 9001827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
